Sunday, July 12, 2020

Multicancer Blood Test Detects Undiagnosed Cancers, Study

A new study has shown that a multicancer blood test detected 26 undiagnosed cancer. The study was conducted on more than 9,900 women, which helped diagnosed undetected cancers, enabling potentially curative treatment. The test along with PET-CT was 99 percent specific to cancers.

Sam Lloyd Dies from Cancer at 56

Sam Lloyd, an American actor, who was best known for playing Ted Buckland on Scrubs in 95 episodes, has died after battling cancer at the age of 56. He also appeared on Cougar Town, Seinfeld, and The West Wing. He was diagnosed with a brain tumor last year.

FDA Approves Additional Doses of Cancer Drug Keytruda in Adults

The Food and Drug Administration (FDA) announced accelerated approval of the additional recommended dosage of a cancer drug called Keytruda (pembrolizumab) in adults, given the severity of the ongoing coronavirus pandemic. The FDA approved the dosage of 400 mg every 6 weeks.

FDA Approves Trodelvy for Metastatic Triple-Negative Breast Cancer

The Food and Drug Administration has granted accelerated approval of a drug called Trodelvy (sacituzumab govitecan-hziy) for the treatment of metastatic triple-negative breast cancer (TNBC) in adult patients. The accelerated approval would allow doctors to treat the most aggressive form of the disease.

James Lipton Dies from Bladder Cancer at the Age Of 93

James Lipton, dean emeritus of the Actors Studio Drama School has passed away after battling bladder cancer at the age of 93. He was a scriptwriter, author, lyricist, producer, choreographer, and academic. He served the Inside the Actors Studio since 1994, which grants Master of Fine Arts degrees in acting, directing, and playwriting.

Omega-3 Supplements Offer No Protection against Cancer, Finds Study

A new study, which was funded by the World Health Organization (WHO), has found that fish oil or omega-3 fatty acid supplements offer “little to no” protection against cancer. Researchers from the University of Anglia has found that the billion-dollar industry of supplements offer no health benefits as they claim.

FDA Approves NDA for Neratinib Along With Capecitabine for Metastatic Breast Cancer

The FDA announced the approval of a supplemental new drug application (sNDA) of neratinib in combination with capecitabine for the treatment of advanced breast cancer. Neratinib, developed by Puma Biotechnology, announced the FDA approval for its drug for metastatic breast cancer.